Erik Mittra
Division Chief, Molecular Imaging and Therapy · Oregon Health & Science University
Credentials: · · · · ·
History
- Present
Molecular Imaging and Therapy Division · Oregon Health & Science University
- Present
Nuclear Medicine Section · Oregon Health & Science University
2008–2009
2006–2008- 2005–2006
M.D., Ph.D., 2005, Stony Brook University MSTP Program
Research
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · 2,601 citations
Nature Medicine · 2012 · 712 citations
The Lancet Oncology · 2021 · 510 citations
31 papers · 2 as a fellow
27 papers
- NM
10 papers
9 papers
8 papers
- JS
7 papers
7 papers
- MJ
6 papers
Grants
- 2021–2026
National Cancer Institute · R01
PI · $575.7K · Oregon Health & Science University
Clinical trials
- 2022–2026
Principal investigator · Terminated · Phase 2
CellSight Technologies, Inc.
- 2014–2015
Principal investigator · Terminated
Erik Mittra